Kennedy expands role in FDA decision-making

The Trump administration is extending political influence over FDA regulatory decisions, moving from vaccines to abortion drugs.

Last week, HHS Secretary Robert F. Kennedy Jr. sent a letter to 20 state attorneys general, pledging that FDA would consider evidence they submitted in August about the abortion pill mifepristone. FDA Commissioner Marty Makary co-signed the letter. ...